Medicare Enrolled

Dr. Sammy Saab, MD

Transplant Surgery Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
100 UCLA MEDICAL PLZ STE 700, Los Angeles, CA 90024
3107947783
In practice since 2006 (19 years)
NPI: 1720008899 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Saab from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saab? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Saab

Dr. Sammy Saab is a transplant surgery physician in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Saab performed 1,090 Medicare services across 817 unique beneficiaries.

Between the years covered by Open Payments, Dr. Saab received a total of $1,975,779 from 39 pharmaceutical and/or device companies across 1810 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in transplant surgery physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Saab is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 5% volume in CA $1,975,779 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,090
Medicare services
Top 5% in CA for transplant surgery physician
817
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~57 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
487 $76 $858
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
224 $24 $354
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
217 $53 $508
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
53 $108 $1,085
Online digital E/M service, established patient, 11-20 min
An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days.
41 $18 $138
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
23 $111 $890
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
17 $68 $470
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
14 $8 $94
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
14 $149 $1,320
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,975,779
Total received (2018-2024)
Avg $282,254/year across 7 years
Top 1% in CA for transplant surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
1,810
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,879,980 (95.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$93,196 (4.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,603 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$242,711
2023
$259,994
2022
$233,425
2021
$211,150
2020
$135,311
2019
$463,529
2018
$429,657

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$64,006
Gilead Sciences, Inc.
$63,840
Ipsen Biopharmaceuticals, Inc
$43,277
Mallinckrodt Hospital Products Inc.
$26,455
Madrigal Pharmaceuticals
$23,440
Boehringer Ingelheim Pharmaceuticals, Inc.
$13,964
ABBVIE INC.
$3,451
ORPHALAN INC
$3,029
Intercept Pharmaceuticals, Inc.
$776
GlaxoSmithKline, LLC.
$232
Lilly USA, LLC
$96
FUJIFILM Healthcare Americas Corporation
$59
Alnylam Pharmaceuticals Inc.
$57
Takeda Pharmaceuticals U.S.A., Inc.
$29
Top 3 companies account for 70.5% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$522,654
Gilead Sciences, Inc.
$518,445
AbbVie, Inc.
$157,535
Mallinckrodt Hospital Products Inc.
$151,353
Dova Pharmaceuticals
$74,636
Intercept Pharmaceuticals, Inc.
$74,255
Exelixis Inc.
$59,263
Takeda Pharmaceuticals U.S.A., Inc.
$54,734
Bayer HealthCare Pharmaceuticals Inc.
$48,989
Ipsen Biopharmaceuticals, Inc
$43,277
EISAI INC.
$40,755
ABBVIE INC.
$35,469
Eisai Inc.
$31,178
Madrigal Pharmaceuticals
$23,440
AbbVie Inc.
$23,108
INTERCEPT PHARMACEUTICALS, INC.
$22,985
E.R. Squibb & Sons, L.L.C.
$20,757
Shionogi Inc
$17,002
Boehringer Ingelheim Pharmaceuticals, Inc.
$13,964
SWEDISH ORPHAN BIOVITRUM AB
$12,580
Novartis Pharmaceuticals Corporation
$9,363
Merck Sharp & Dohme Corporation
$9,190
ORPHALAN INC
$3,184
PFIZER INC.
$2,645
Alexion Pharmaceuticals, Inc.
$1,900
FUJIFILM Wako Diagnostics U.S.A. Corporation
$847
Janssen Pharmaceuticals, Inc
$750
Alnylam Pharmaceuticals Inc.
$401
Novo Nordisk Inc
$279
GlaxoSmithKline, LLC.
$232
Mirum Pharmaceuticals, Inc.
$185
Lilly USA, LLC
$166
CALLIDITAS THERAPEUTICS US INC.
$79
FUJIFILM Healthcare Americas Corporation
$59
W. L. Gore & Associates, Inc.
$41
Eiger BioPharmaceuticals, Inc.
$34
Agios Pharmaceuticals, Inc.
$23
EIGER BIOPHARMACEUTICALS, INC.
$16
Travere Therapeutics, Inc.
$8
Top 3 companies account for 60.7% of all-time payments
Associated products mentioned in payments ›
CABOMETYX · CUVRIOR · Cabometyx · Cholbam · DOPTELET · Doptelet · ELOCTATE · ENTYVIO · Epclusa · GIVLAARI · GORE CARDIOFORM Septal Occluder · Harvoni · IQIRVO · LIVTENCITY · Lenvima · Livdelzi · Livmarli · MAVYRET · Mavyret · Mulpleta · Nexavar · OCALIVA · OPDIVO · OXLUMO · Ozempic · PYRUKYND · RESMETIROM · REZDIFFRA · RIFAXIMIN · Saxenda · Stivarga · TARPEYO · TERLIVAZ · UCERIS · UTASWAKO AFP-L3 · Vemlidy · Wako HCC Biomarker(s) DCP and AFP-L3 · Wegovy · XIFAXAN · XIFIXAN · ZEPATIER · ZOKINVY · ZORTRESS
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in transplant surgery physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for transplant surgery physician in CA.

Looking for a transplant surgery physician in Los Angeles?
Compare transplant surgery physicians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse transplant surgery physicians nearby

Geographic Context

Transplant surgery physicians within 10 mi
41
Per 100K population
0.4
County median income
$87,760
Nearest hospital
RONALD REAGAN UCLA MEDICAL CENTER
0.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Saab is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Saab experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Saab performed 487 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saab receive payments from pharmaceutical companies?
Yes. Dr. Saab received a total of $1,975,779 from 39 companies across 1,810 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saab's costs compare to other transplant surgery physicians in Los Angeles?
Dr. Saab's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saab) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →